Peter Dellva

Biography

    Peter Dellva joined BioTechLogic in 2004 as the Head of Business and Finance. He has over 22 years of experience in the biopharmaceutical industry. He currently oversees all financial and administrative aspects of BioTechLogic’s business. Prior to joining BioTechLogic, Mr. Dellva led a team of 13 professionals that provided manufacturing strategy, sourcing strategies, contract manufacturing development and management, process validation, and supply chain management for clinical and commercial proteins within Pfizer’s (previously Pharmacia’s) biopharma organization. He was responsible for development of Pharmacia’s Biotechnology Manufacturing Strategy to support current and future protein products, including the successful startup, validation and commercialization of Somavert® API. He negotiated and managed clinical and commercial supply agreements with total value in excess of $200 million with major biotech industry CMOs in the U.S. and Europe as well as developing financial systems to manage virtual (all external) manufacturing supply chains. From 1993-1999, he provided on-site management of commercial and clinical protein production at multiple sites for G.D. Searle, a division of Monsanto. He holds a B.S. in Chemical Engineering from Iowa State University, an M.M. in Finance and International Business and an M.S. in Biotechnology, both from Northwestern University.  

Research Interest

   Drug Development & Research, Development in Pharmacy & Life Sciences